IBL News

LRG (Leucine-Rich alpha-2-Glycoprotein) is a novel protein reported as a protein consists of leucine-rich repeat structure first time. Although human LRG sequence was determined long time ago (it was determined in 1985), its physiological function had not been revealed for a long time because no measuring method was established for accurately measuring LRG. LRG has been recognized as a protein that elevates in various diseases such as idiopathic normal pressure hydrocephalus, diabetes, cancers and various type of inflammatory diseases. A paper indicated LRG would be also candidate of a new biomarker of pancreatic cancer has been also published.
 
#27769 Human LRG Assay kit is used in the following article.
Please click the following link to learn more this study.
Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. K Furukawa et al. Pancreas. 2015 Jan;44(1):93-98. PMID: 25058884


Please feel free to contact us with regard to the products.

Immuno-Biological Laboratories Co., Ltd.
Diagnostic Research Reagent Division
Sales Support
TEL: +81-274-50-8666
Email: do-ibl@ibl-japan.co.jp